Community/Retail

Drawing on years of experience, Rina Shah explains how sustainable care models are essential for a thriving pharmaceutical industry.

Communities that are impacted by increased wildfires can experience increased health risks, particularly among those who have asthma or chronic obstructive pulmonary disease.

In an interview with Pharmacy Times, Jon Easter discusses the need for pharmacy to align as a profession to achieve policy and research goals.

The legal question was whether a statute created an enforceable contract

Tune into this episode of “Public Health Matters” to learn about how Healthcare Advocate Summit, created by advocates for advocates, is involved in the discussion on improving access to health care.

President of NACDS, Steve Anderson, discusses how the events at Total Store Expo reflect on the association's goals of innovation and a focus on public policy.

Pharmacists are key resource points to navigate the nuances of keto diets and chronic health management.

When a community loses a pharmacy, it loses a trusted health care provider. Understanding the root causes of these closures—and what we can do about it—can drive change.

Biosimilar etanercept (Sunshine Guojian Pharmaceutical) showed similar therapeutic outcomes compared with etanercept (Enbrel; Amgen) specific to rheumatoid arthritis.

Sara Roszak recounts the Annual NACDS Foundation Dinner and their role in implementing research at the clinical level.

Brandon Newman highlights the need for balanced regulation, transparency, and real-time data access to ensure fair competition and optimal outcomes for pharmacy benefit mangers.

The money could be used for prevention and treatment services, health care practitioner training, or other ways to stem the epidemic.

The decision by the Supreme Court has the potential to upend the power of regulatory agencies to shape the health care landscape of the country.

These pharmacies bring high-touch specialty pharmacies into local communities for patients with more complex needs.

Joseph Saseen offers valuable insights into the implications of the added performance and quality measures for patients and health care providers.

Jasmine Perry discusses the More Than a Script program in an interview with Pharmacy Times.

Brandon Newman discusses the significant influence of the "big 3" pharmacy benefit managers and the key legislative and regulatory efforts around transparency.

In a session at NACDS Total Store Expo, experts spoke to the success of value-based care models in the pharmaceutical industry.

Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.

The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.

The biosimilar space continues to grow, with key focuses around retina and oncology, but adoption remains slow in the United States.

The OTC antibody test can detect current or past infection but should be followed by additional testing to confirm diagnosis.

Glucagon-like peptide-1 receptor agonists and sodium-glucose contransporter-2 inhibitors have been added as first-line therapy recommendation for type 2 diabetes, the first since metformin

Pharmacists should educate patients about proper medication storage and offer naloxone to optimize safety.

Sara Roszak discusses her role as president of the NACDS Foundation.

Scott Biggs and Doug Long explain current trends in the pharmaceutical industry and the importance of ensuring pharmacists are informed.

Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.